267 related articles for article (PubMed ID: 30982895)
1. Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
Chirikov VV; Simões EAF; Kuznik A; Kwon Y; Botteman M
J Infect Dis; 2020 Mar; 221(8):1244-1255. PubMed ID: 30982895
[TBL] [Abstract][Full Text] [Related]
2. Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
Simões EAF; Chirikov V; Botteman M; Kwon Y; Kuznik A
J Infect Dis; 2020 Mar; 221(8):1256-1270. PubMed ID: 31165865
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
[TBL] [Abstract][Full Text] [Related]
4. Healthcare costs within a year of respiratory syncytial virus among Medicaid infants.
Palmer L; Hall CB; Katkin JP; Shi N; Masaquel AS; McLaurin KK; Mahadevia PJ
Pediatr Pulmonol; 2010 Aug; 45(8):772-81. PubMed ID: 20632403
[TBL] [Abstract][Full Text] [Related]
5. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention.
Stewart DL; Romero JR; Buysman EK; Fernandes AW; Mahadevia PJ
Curr Med Res Opin; 2009 Nov; 25(11):2795-804. PubMed ID: 19788406
[TBL] [Abstract][Full Text] [Related]
6. Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants.
Shi N; Palmer L; Chu BC; Katkin JP; Hall CB; Masaquel AS; Mahadevia PJ
J Med Econ; 2011; 14(3):335-40. PubMed ID: 21524154
[TBL] [Abstract][Full Text] [Related]
7. Cumulative incidence of post-infection asthma or wheezing among young children clinically diagnosed with respiratory syncytial virus infection in the United States: A retrospective database analysis.
Nguyen-Van-Tam J; Wyffels V; Smulders M; Mazumder D; Tyagi R; Gupta N; Gavart S; Fleischhackl R
Influenza Other Respir Viruses; 2020 Nov; 14(6):730-738. PubMed ID: 32533658
[TBL] [Abstract][Full Text] [Related]
8. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life.
Escobar GJ; Ragins A; Li SX; Prager L; Masaquel AS; Kipnis P
Arch Pediatr Adolesc Med; 2010 Oct; 164(10):915-22. PubMed ID: 20921348
[TBL] [Abstract][Full Text] [Related]
9. Risk of childhood wheeze and asthma after respiratory syncytial virus infection in full-term infants.
Mejias A; Wu B; Tandon N; Chow W; Varma R; Franco E; Ramilo O
Pediatr Allergy Immunol; 2020 Jan; 31(1):47-56. PubMed ID: 31566811
[TBL] [Abstract][Full Text] [Related]
10. Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma.
Jalink MB; Langley JM; Dodds L; Andreou P
Pediatr Infect Dis J; 2019 Nov; 38(11):1121-1125. PubMed ID: 31425330
[TBL] [Abstract][Full Text] [Related]
11. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
Amand C; Tong S; Kieffer A; Kyaw MH
BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
[TBL] [Abstract][Full Text] [Related]
12. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
[TBL] [Abstract][Full Text] [Related]
13. Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study.
Thampi N; Knight BD; Thavorn K; Webster RJ; Lanctot K; Hawken S; McNally JD
CMAJ Open; 2021; 9(4):E948-E956. PubMed ID: 34667075
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy.
Dovizio M; Veronesi C; Bartolini F; Cavaliere A; Grego S; Pagliaro R; Procacci C; Ubertazzo L; Bertizzolo L; Muzii B; Parisi S; Perrone V; Baraldi E; Bozzola E; Mosca F; Esposti LD
Ital J Pediatr; 2024 Mar; 50(1):57. PubMed ID: 38528616
[TBL] [Abstract][Full Text] [Related]
15. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
Zhang S; Akmar LZ; Bailey F; Rath BA; Alchikh M; Schweiger B; Lucero MG; Nillos LT; Kyaw MH; Kieffer A; Tong S; Campbell H; Beutels P; Nair H;
J Infect Dis; 2020 Oct; 222(Suppl 7):S680-S687. PubMed ID: 32227101
[TBL] [Abstract][Full Text] [Related]
16. Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020.
Gantenberg JR; van Aalst R; Zimmerman N; Limone B; Chaves SS; La Via WV; Nelson CB; Rizzo C; Savitz DA; Zullo AR
J Infect Dis; 2022 Aug; 226(Suppl 2):S164-S174. PubMed ID: 35968869
[TBL] [Abstract][Full Text] [Related]
17. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
18. Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants.
Ledbetter J; Brannman L; Wade SW; Gonzales T; Kong AM
J Med Econ; 2020 Feb; 23(2):139-147. PubMed ID: 31432723
[No Abstract] [Full Text] [Related]
19. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
[TBL] [Abstract][Full Text] [Related]
20. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study.
Ares-Gómez S; Mallah N; Pardo-Seco J; Malvar-Pintos A; Pérez-Martínez O; Otero-Barrós MT; Súarez-Gaiche N; Santiago-Pérez MI; González-Pérez JM; López-Pérez LR; Rosón B; Alvárez-Gil RM; Ces-Ozores OM; Nartallo-Penas V; Mirás-Carballal S; Rodríguez-Tenreiro C; Rivero-Calle I; Salas A; Durán-Parrondo C; Martinón-Torres F
Pediatr Allergy Immunol; 2024 May; 35(5):e14131. PubMed ID: 38700124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
